Geburtshilfe Frauenheilkd 2014; 74(8): 721-732
DOI: 10.1055/s-0034-1382874
Guideline
GebFra Science
Georg Thieme Verlag KG Stuttgart · New York

S1-Guideline on the Use of CTG During Pregnancy and Labor

Long version – AWMF Registry No. 015/036S1-Leitlinie Anwendung des CTG während Schwangerschaft und GeburtLangfassung – AWMF-Register-Nr. 015/036
K. T. M. Schneider (corresponding author)
,
German Society of Gynecology and Obstetrics (DGGG), Maternal Fetal Medicine Study Group (AGMFM), German Society of Prenatal Medicine and Obstetrics (DGPGM), German Society of Perinatal Medicine (DGPM)
Further Information

Publication History

Publication Date:
03 September 2014 (online)

1 Purpose

1.1 Aim, target audience and method

The aim of this consensus paper is to standardize the use of cardiotocograms (CTG) in fetal monitoring using an evidence-based approach. Recommended standards take the impact of disturbances and other influencing variables on the CTG into account, use standard definitions and objective assessment methods, and look at upstream diagnostic procedures and adjunct monitoring methods.

The target audience for this consensus paper are all professionals who use CTG readings to monitor pregnancies and childbirth, most notably gynecologists and midwives.

Method: This guideline was compiled with particular reference to and in consideration of previous recommendations [85], the FIGO guidelines [59], [82], and the guidelines of the Royal College of Obstetricians and Gynaecologists [84], the NICHD [72], the Society of Obstetrics and Gynecologists Canada [110] and the American College of Obstetricians and Gynecologists [4], [5] as well as evidence-based data, where available.

The basis for this guideline is the best available “evidence” which was carefully collected and classified by the members of the consensus group.

It was not possible in every case to compile recommendations directly from the evidence level provided in the available literature. The recommendations show what is generally considered good clinical practice, so far as this was not queried by the persons involved in the consensus process. With regard to the requirements specified by the AWMF for the compilation of guidelines in terms of a uniform structure for different guideline types (S1, S2e, S2k, S3), the levels of recommendation in this S1 guideline on recommended actions are not stated explicitly but are indicated using the terms “shall”, “should” and “can”. Transparency is given in the background text, which lists the level of evidence of cited studies.

The level of evidence is as follows ([Table 1]):

Table 1 Evidence level (EL) (from [84]).*

Level

Evidence

* The first version of this guideline was compiled in 2003 and published in 2004, in other words, prior to the development of the DELBI and AWMF criteria for defining the level of evidence. The level of evidence was determined in analogy to the evaluation of guidelines issued by foreign professional associations (s. above) and this form of assessment was retained in the revised version of the guidelines.

I a

Systematic review with meta-analysis of randomized controlled studies

I b

At least one randomized controlled trial

II a

At least one well-designed controlled study without randomization

II b

At least one other type of well-designed quasi-experimental study

III

Well-designed non-experimental descriptive study, e.g. comparative, correlation and case studies

IV

Expert committee reports or opinions and/or clinical experiences of respected authorities


#
 
  • 11 References

  • 1 Agrawal SK, Doucette F, Gratton R et al. Intrapartum computerized fetal heart rate parameters and metabolic acidosis at birth. Obstet Gynecol 2003; 102: 731-738
  • 2 Alfirevic Z, Neilson JP. Biophysical profile for fetal assessment in high risk pregnancies. Cochrane Database Syst Rev 2008; (1) CD000038
  • 3 Alfirevic Z, Devane D, Gyte GM. Continuous cardiotocography (CTG) as a form of electronic foetal monitoring (EFM) for foetal assessment during labour. Cochrane Database Syst Rev 2006; (3) CD006066
  • 4 ACOG Practice Bulletin No. 106: Intrapartum fetal heart rate monitoring. nomenclature, interpretation, and general management principles. Obstet Gynecol 2009; 114: 192-202
  • 5 ACOG Practice Bulletin No. 116: Management of intrapartum fetal heart rate tracings. Obstet Gynecol 2010; 116: 1232-1240
  • 6 Ashkenazi S, Metzker A, Merlob P et al. Scalp changes after fetal monitoring. Arch Dis Child 1985; 60: 267-269
  • 7 Beckley S, Stenhouse E, Greene K. The development and evaluation of a computer-assisted teaching programme for intrapartum fetal monitoring. BJOG 2000; 107: 1138-1144
  • 8 Berger R, Bender S, Sefkow S et al. Peri/intraventricular haemorrhage: a cranial ultrasound study on 5286 neonates. Eur J Obstet Gynecol Reprod Biol 1997; 75: 191-203
  • 9 Bernardes J, Costa Pereira A, Ayres de Campos D et al. Evaluation of interobserver agreement of cardiotocograms. Int J Gynaecol Obstet 1997; 57: 33-37
  • 10 Bloom SL, Spong CY, Thom E et al. Fetal pulse oximetry and caesarean delivery. New Engl J Med 2006; 355: 195-202
  • 11 Brown VA, Sawers RS, Parsons RJ et al. The value of antenatal cardiotocography in the management of high risk pregnancy: a randomized controlled trial. Br J Obstet Gynaecol 1982; 89: 716-722
  • 12 Butterwegge M, Gonser M, Roemer VM. Stellungnahme zu einem Gutachten der BQS über geburtshilfliche Qualitätsindikatoren. Z Geburtsh Neonatol 2005; 209: 69-75
  • 13 Carbonne B, Langer B, Goffinet F et al. Clinical importance of fetal pulse oximetry. II. Comparative predictive values of oximetry and scalp pH. Multicenter study. J Gynecol Obstet Biol Reprod (Paris) 1999; 28: 137-144
  • 14 Cibilis LA. On intrapartum fetal monitoring. Am J Obstet Gynecol 1996; 174: 1382-1389
  • 15 Chow O, Larbig A, Kabartas B et al. Pitfalls of external FHR-monitoring in the second stage of labor. J Mat Fet Neonat Med 2010; 23 (Suppl.) 236
  • 16 Dawes GS, Moulden M, Redman CWG. Short term fetal heart rate variation, decelerations, and umbilical flow velocity waveforms before labour. Obstet Gynecol 1992; 80: 673-678
  • 17 Daumer M, Scholz M, Boulesteix AL et al. The normal fetal heart rate study: analysis plan. Nature Proceedings 2007;
  • 18 Devoe LD, Ross M, Wilde C et al. United States multicenter clinical usage study of the STAN 21 electronic fetal monitoring system. Am J Obstet Gynecol 2006; 195: 729-734
  • 19 DKG Leitfaden: Aufbewahrungsverpflichtungen und -fristen von Dokumenten im Krankenhaus. NKG Mitteilung 2006; 394
  • 20 Drogtrop AP, Ubels R, Nijhuis JG. The association between fetal body movements, eye movements, and heart rate patterns in pregnanccies between 25 and 30 weeks of gestation. Early Hum Dev 1990; 23: 67-73
  • 21 Dudenhausen JW, Luhr C, Dimer JS. Umbilical artery blood gases in healthy term newborn infants. Int J Gynaecol Obstet 1997; 57: 251-258
  • 22 East CE, Colditz PB. Fetal pulse oximetry for fetal assessment in labour. Cochrane Database Syst Rev 2007; (2) CD004075
  • 23 Elliott C, Warrick PA, Graham E et al. Graded classification of fetal heart rate tracings: association with neonatal metabolic acidosis and neurologic morbidity. Am J Obstet Gynecol 2010; 202: 258.e1-258.e8
  • 24 Fedorkow DM, Stewart TJ, Parboosingh J. Fetal heart rate changes associated with general anestesia. Am J Perinat 1989; 6: 287-288
  • 25 Ferrazzi E, Rigano S, Bozzo M et al. Umbilical vein blood flow in growth-restricted fetuses. Ultrasound Obstet Gynecol 2000; 16: 432-438
  • 26 FDA. Dear Healthcare Provider Letter 3–09/04/2009. Online: http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm181503.htm Stand: 08/2013
  • 27 Flynn AM, Kelly J, Mansfield H et al. A randomized controlled trial of non-stress-antepartum cardiotocography. Br J Obstet Gynaecol 1982; 89: 427-433
  • 28 Gaffney G, Flavell V, Johnson A et al. Cerebral palsy and neonatal encephalopathy. Arch Dis Child Fetal Neonat Ed 1994; 70: F195-F200
  • 29 Gaffney G, Sellers S, Flavell V et al. A case-control study of intrapartum care, cerebral palsy, and perinatal death. Br Med J 1994; 308: 743-750
  • 30 Garcia J, Corry M, MacDonald D et al. Mothersʼ views of continuous electronic fetal heart monitoring and intermittent auscultation in a randomized controlled trial. Birth 1985; 12: 79-86
  • 31 Garite TJ, Dildy GA, McNamara H et al. A multicenter controlled trial of fetal pulse oximetry in the intrapartum management of nonreassuring fetal heart rate patterns. Am J Obstet Gynecol 2000; 183: 1049-1058
  • 32 Garnier Y, Coumans A, Berger R et al. Endotoxemia severely affects circulation during normoxia and asphyxia in immature fetal sheep. J Soc Gynecol Invest 2001; 8: 134-142
  • 33 Gnirs J, Schelling M, Kolben M et al. Referenzkurven für das fetale Bewegungsprofil. Geburtsh Frauenheilk 1998; 58: 355-362
  • 34 Gonser M, König M, Marzusch K. Schema zur CTG-Interpretation nach den FIGO-Richtlinien. Gynäkol Prax 1995; 19: 649-659
  • 35 Graatsma EM, Jacod BC, van Egmond LAJ et al. Fetal electrocardiotocography: feasibility of long-term fetal heart rate recordings. BJOG 2009; 116: 334-337
  • 36 Grant A, OʼBrien N, Joy MT et al. Cerebral palsy among children born during the Dublin randomised trial of intrapartum monitoring. Lancet 1989; 8674: 1233-1236
  • 37 Grivel RM, Alfirevic Z, Gyte GM et al. Antenatal cardiotocography for foetal assessment. Cochrane Database Syst Rev 2010; (1) CD007863
  • 38 Hansen PK, Smith SF, Nim J et al. Maternal attitudes to fetal monitoring. Eur J Obstet Gynecol Reprod Biol 1985; 20: 43-51
  • 39 Haverkamp AD, Thompson HE, McFee JG et al. The evaluation of continuous fetal heart rate monitoring in high-risk pregnancy. Am J Obstet Gynecol 1976; 125: 310-317
  • 40 Haverkamp AD, Orleans M, Langendoerfer S et al. A controlled trial of the differential effects of intrapartum fetal monitoring. Am J Obstet Gynecol 1979; 134: 399-412
  • 41 Herbst A, Ingemarsson I. Intermittent versus continuous electronic fetal monitoring in labour: a randomized study. Br J Obstet Gynaecol 1994; 101: 663-668
  • 42 Hod M, Kerner R. Telemedicine for antenatal surveillance of high-risk pregnancies with ambulatory and home fetal heart monitoring–an update. J Perinat Med 2003; 31: 195-200
  • 43 Impey L, Reynolds M, MacQuillan K et al. Admission cardiotocography: a randomised controlled trial. Lancet 2003; 361: 465-470
  • 44 Jensen A, Martius G. Überwachung und Leitung der Entbindung. In: Martius G, Rath W, Hrsg. Geburtshilfe und Perinatologie. Stuttgart: Thieme; 1991: 386-442
  • 45 Jensen A, Roman C, Rudolph AM. Effects of reducing uterine blood flow distribution and oxygen delivery. J Dev Physiol 1991; 15: 309-323
  • 46 Keith RD, Beckley S, Garibaldi JM et al. A multicentre comparative study of 17 experts and an intelligent computer system for managing labour using the cardiotocogram. Br J Obstet Gynaecol 1995; 102: 688-700
  • 47 Kelso AM, Parsons RJ, Lawrence GF et al. An assessment of continuous fetal heart rate monitoring in labor. Am J Obstet Gynecol 1978; 131: 526-532
  • 48 Kidd L, Patel N, Smith R. Non-stress antenatal cardiotocography – a prospective randomized clinical trial. Br J Obstet Gynaecol 1985; 92: 1156-1159
  • 49 Killien MG, Shy K. A randomized trial of electronic fetal monitoring in preterm labor: motherʼs views. Birth 1989; 16: 7-12
  • 50 Kühnert M, Schmidt S. Intrapartum management of nonreassuring fetal heart rate patterns: a randomized controlled trial of fetal pulse oximetry. Am J Obstet Gynecol 2004; 191: 1989-1995
  • 51 Kühnert M, Hellmeyer L, Stein W et al. Twenty-four-hour CTG monitoring: comparison of normal pregnancies of 25-30 weeks of gestation versus 36-42 weeks of gestation. Arch Gynecol Obstet 2007; 275: 451-460
  • 52 Langendoerfer S, Haverkamp AD, Murphy J et al. Pediatric follow up of a randomised controlled trial of intrapartum fetal monitoring techniques. J Ped 1980; 97: 103-107
  • 53 Leveno KJ, Cunningham FG, Nelson S et al. A prospective comparison of selective and universal electronic fetal monitoring in 34,995 pregnancies. N Engl J Med 1986; 315: 615-619
  • 54 Liston R, Sawchuck D, Young D. Fetal health surveillance: antepartum and intrapartum consensus guideline. J Obstet Gynecol Canada 2007; 29 (Suppl. 04) 3-56
  • 55 Lotgering FK, Wallenburg HC, Schouten HJ. Interobserver and intraobserver variation in the assessment of antepartum cardiotocograms. Am J Obstet Gynecol 1982; 144: 701-705
  • 56 Lumley J, Lester A, Anderson I et al. A randomized trial of weekly cardiotocography in high-risk obstetric patients. Br J Obstet Gynaecol 1983; 90: 1018-1026
  • 57 Luthy DA, Shy KK, van Belle G. A randomized trial of electronic fetal heart monitoring in premature labor. Obstet Gynecol 1987; 69: 687-695
  • 58 MacDonald D, Grant A, Sheridan-Perreira M. The Dublin randomized controlled trial of intrapartum fetal heart rate monitoring. Am J Obstet Gynecol 1985; 152: 524-539
  • 59 Maeda K. FIGO News: Report of the FIGO Study Group on the Assessment of New Technology. Evaluation and standardization of fetal monitoring. Int J Gynaecol Obstet 1997; 59: 169-173
  • 60 Mahomed K, Nyoni R, Mulambo T et al. Randomised controlled trial of intrapartum fetal heart rate monitoring. Br Med J 1994; 308: 497-500
  • 61 Macones GA, Hankins GD, Spong CY et al. The 2008 National Institute of Child Health and Human Development workshop report on electronic fetal monitoring: update on definitions, interpretation and research guidelines. Obstet Gynecol 2008; 112: 661-666
  • 62 Mardirosoff C, Dumont L, Boulvain M et al. Fetal bradycardia due to intrathecal opioids for labour analgesia: a systematic review. BJOG 2002; 109: 274-281
  • 63 Miller DA, Rabello YA, Paul RH. The modified biophysical profile: antepartum testing in the 1990s. Am J Obstet Gynecol 1996; 174: 812-817
  • 64 Morgenstern J, Abels T, Somville T et al. Accuracy of fetal heart rate monitoring. Gynäkologe 1994; 27: 123-129
  • 65 Murray ML, Higgins P. Computer versus lecture: strategies for teaching fetal monitoring. J Perinatol 1996; 16: 15-19
  • 66 National Health and Medical Research Council. How to review the Evidence: systematic Identification and Review of the scientific Literature. Canberra: Biotext; 1999
  • 67 Neilson JP. Fetal electrocardiogram (ECG) for fetal monitoring during labour. Cochrane Database Syst Rev 2012; (4) CD000116
  • 68 Neilson jr. DR, Freeman RK, Mangan S. Signal ambiguity resulting in unexpected outcome with external fetal heart rate monitoring. Am J Obstet Gynecol 2008; 199: 717-724
  • 69 Neldam S, Osler M, Hansen PK et al. Monitoring labor with cardiotocography and stethoscopic examination in normal and risk deliveries. Ugeskr Laeger 1985; 147: 2901-2907
  • 70 Neldam S, Osler M, Hansen PK et al. Intrapartum fetal heart rate monitoring in a combined low- and high-risk population: a controlled clinical trial. Eur J Obstet Gynecol Reprod Biol 1986; 23: 1-11
  • 71 Nelson KB, Dambrosia JM, Ting TY et al. Uncertain value of electronic fetal monitoring in predicting cerebral palsy. N Engl J Med 1996; 334: 613-618
  • 72 NICHD (National Institute of Child Health and Human Development). Electronic fetal heart rate monitoring: Research guidelines for interpretation. Research Planning Workshop. Am J Obstet Gynecol 1997; 177: 1385-1390
  • 73 Nijhuis JG, van de Pas M. Behavioral states and their ontogeny: human studies. Semin Perinatol 1992; 16: 206-210
  • 74 Noren H, Blad S, Carlsson A et al. STAN in clinical practice – The outcome of 2 years of regular use in the city of Gothenburg. Am J Obstet Gynecol 2006; 195: 7-15
  • 75 OLG Oldenburg 15.5.90 5 U 114/89; OLG Karlsruhe 28.11.97 U 28/79; OLG Hamburg 30.03.79 1 U 115/77; BGH NJW 1992, 1560=VersR 1992: 745.
  • 76 Parer JT, King TL. Fetal heart rate monitoring: the next step?. Am J Obstet Gynecol 2010; 202: 520-521
  • 77 Pattison N, McCowan L. Cardiotocography for antepartum fetal assessment (Cochrane Review). Cochrane Database Syst Rev 2010; (1) CD001068
  • 78 Petrie RH, Yeh SY, Murata Y et al. The effects of drugs on fetal heart rate variability. Am J Obstet Gynecol 1987; 130: 294-299
  • 79 Renou P, Chang A, Anderson I. Controlled trial of fetal intensive care. Am J Obstet Gynecol 1976; 126: 470-476
  • 80 Roemer VM. Quantitative CTG-Bewertung sub partu mit einem neuen CTG-Score: Wie gut sind die Korrelationen mit den Parametern des fetalen Säure-Basen-Haushaltes im Nabelschnurblut?. Z Geburtshilfe Neonatol 2003; 207: 121-126
  • 81 Rooth G. Perinatal Acid-base Balance. Lund: Studentlitteratur; 1988
  • 82 Rooth G, Huch A, Huch R. FIGO News: Guidelines for the use of fetal monitoring. Int J Gynaecol Obstet 1987; 25: 159-167
  • 83 Rosen KG. Fetal electrocardiogram waveform analysis in labour. Curr Opin Obstet Gynecol 2005; 17: 147-150
  • 84 Royal College of Obstetricians and Gynaecologists. Intrapartum care. London/UK, Sept. 2007.
  • 85 Rüttgers H. Kardiotokographie. Standards in der Perinatalmedizin. Perinat Med 1989; 1: 9-14
  • 86 Samueloff A, Langer O, Berkus M et al. Is fetal heart rate variability a good predictor of fetal outcome?. Acta Obstet Gynecol Scand 1994; 73: 39-44
  • 87 Saling E. Das Kind im Bereich der Geburtshilfe. Stuttgart: Thieme; 1966
  • 88 Schiermeier S, Westhof G, Daumer M et al. Die Kurzzeitvariation der fetalen Herzfrequenz und der FIGO-CTG-Score. Erste Erfahrungen in der Kombination dieser Überwachungsparameter. Geburtsh Frauenheilk 2006; 66: 752-755
  • 89 Schindler T. Delayed Moving Window Algorithm for Online Cardiotocogram Analysis: aComparison of computerized CTG Analysis. 1st ed. Aachen: Verlag Mainz; 2002
  • 90 Schneider KTM. Die Überwachung der Geburt aus forensischer Sicht. Gynäkologe 1994; 27: 212-221
  • 91 Schneider KTM, Bung P, Weber S et al. An orthostatic uterovascular syndrome – a prospective, longitudinal study. Am J Obstet Gynecol 1993; 169: 183-189
  • 92 Shy KK, Luthy DA, Bennett FC et al. Effects of electronic fetal heart rate monitoring, as compared with periodic auscultation, on neurologic development of premature infants. N Engl J Med 1990; 322: 588-593
  • 93 Spencer JA, Badawi N, Burton P et al. The intrapartum CTG prior to neonatal encephalopathy at term: a case-control study. Br J Obstet Gynaecol 1997; 104: 25-28
  • 94 Staisch KJ, Westlake JR, Bashore RA. Blind oxytocin challenge test and perinatal outcome. Am J Obstet Gynecol 1980; 138: 399-403
  • 95 Street P, Dawes GS, Moulden M et al. Short term variation in abnormal antenatal fetal heart rate records. Am J Obstet Gynecol 1991; 165: 515-523
  • 96 Tan KH, Smyth R. Fetal vibroacoustic stimulation for facilitation of tests of fetal wellbeing (Cochrane Review). Cochrane Database Syst Rev 2013; (12) CD002963
  • 97 Thacker SB, Berkelman RL. Assessing the diagnostic accuracy and efficacy of selected antepartum fetal surveillance techniques. Obstet Gynecol Surv 1986; 41: 121-141
  • 98 Thacker SB, Stroup D, Chang M. Continuous electronic heart rate monitoring for fetal assessment during labor (Cochrane Review). Cochrane Database Syst Rev 2013; (5) CD006066
  • 99 Trimbos JB, Keirse MJ. Observer variability in assessment of antepartum cardiotocograms. Br J Obstet Gynaecol 1978; 85: 900-906
  • 100 Van Geijn HP, Jongsma HW, Doesburg WH et al. The effect of diazepam administration during pregnancy or labor on the heart rate variability of the newborn infant. Eur J Obstet Gynecol Reprod Biol 1980; 10: 187-201
  • 101 Van Woerden EE, van Geijn HP. Factors influencing the fetal Heart Rate. In: van Geijn HP, Copray FJA, eds. A critical Appraisal of fetal Surveillance. Amsterdam: Excerpta Medica; 1994: 211-220
  • 102 Vintzileos AM, Antsaklis A, Varvarigos I et al. A randomized trial of intrapartum electronic fetal heart rate monitoring versus intermittent auscultation. Obstet Gynecol 1993; 81: 899-907
  • 103 Vintzileos AM, Nochimson DJ, Antsaklis A et al. Comparison of intrapartum electronic fetal heart rate monitoring versus intermittent auscultation in detecting fetal acidemia at birth. Am J Obstet Gynecol 1995; 173: 1021-1024
  • 104 Vintzileos AM, Nochimson DJ, Guzman ER et al. Intrapartum electronic fetal heart rate monitoring versus intermittent auscultation: a meta-analysis. Obstet Gynecol 1995; 85: 149-155
  • 105 Visser GH, Dawes GS, Redman CW. Numerical analysis of the normal human antenatal fetal heart rate. Br J Obstet Gynaecol 1981; 88: 792-802
  • 106 Voigt M, Schneider KT, Jahrig K. Analyse des Geburtengutes des Jahrgangs 1992 der Bundesrepublik Deutschland. Teil 1: Neue Perzentilwerte für die Körpermaße von Neugeborenen. Geburtsh Frauenheilk 1996; 56: 550-558
  • 107 Westergaard HB, Langhoff-Roos J, Lingman G et al. A critical appraisal in high-risk pregnancies: use of meta-analysis in evidence-based obstetrics. Ultrasound Obstet Gynecol 2001; 17: 466-476
  • 108 Westerhuis ME, Moons KG, van Beek E et al. A randomised clinical trial on cardiotocography plus fetal blood sampling versus cardiotocography plus ST-analysis of the fetal electrocardiogram (STAN(R)) for intrapartum monitoring. BMC Pregnancy Childbirth 2007; 26: 13
  • 109 Wood C, Renou P, Oats J et al. A controlled trial of fetal heart rate monitoring in a low-risk obstetric population. Am J Obstet Gynecol 1981; 141: 527-534
  • 110 The Society of Obstetricians and Gynaecologists of Canada. Clinical Practice Guideline Fetal Health Surveillance: Antepartum and Intrapartum Consensus Guideline No. 197 (Replaces No. 90 and No. 112), Ottawa/Kanada: SOGC; September 2007.
  • 111 Young DC, Gray JH, Luther ER et al. Fetal scalp blood sampling: its value in an active obstetric unit. Am J Obstet Gynecol 1980; 136: 276-281
  • 112 Zalar jr. RW, Quilligan EJ. The influence of scalp sampling on the cesarean section rate for fetal distress. Am J Obstet Gynecol 1979; 135: 239-246